Biotech & pharma
Finding molecular targets of an HIV drug used in cancer therapy
By By Debra Kain | 29 Apr 2011
Mother’s diet can alter the function of her child’s DNA
28 Apr 2011
Scientists have discovered that a mother’s nutrition during pregnancy can strongly influence her child’s risk of obesity many years later.
The bacterial thermostat
27 Apr 2011
NeuroImage: multiplexing in the visual brain
26 Apr 2011
Scientists prove new technology to control malaria-carrying mosquitoes
23 Apr 2011
Researchers have demonstrated how some genetic changes can be introduced into large laboratory mosquito populations over the span of a few generations by just a small number of modified mosquitoes.
C. difficile increases risk of death six-fold in patients with inflammatory bowel disease
23 Apr 2011
SDSC to venture capitalists: data-intensive supercomputing is here
By By Jan Zverina | 23 Apr 2011
Filters that reduce ‘brain clutter’ identified
20 Apr 2011
More migraines for no apparent reason
18 Apr 2011
Quest for designer bacteria uncovers a spy
16 Apr 2011
Scientists have discovered a molecular assistant called Spy that helps bacteria excel at producing proteins for medical and industrial purposes.
Advanced optical imaging aids cancer diagnosis, treatment
12 Apr 2011
Bioengineering graduate student Carolyn Schutt has helped develop a method that may enhance the diagnosis and treatment of cancer.
Nano pores help boost enzymatic activity
09 Apr 2011
The discovery opens up entirely new possibilities related to biology, chemistry, medicine, and nano engineering
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
